Health

Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.

Bayer's impact investment arm returned for the round's $45m second close, as Triumvera looks to progess its solid tumour therapeutic candidate.

With a remit across healthcare, life sciences and advanced materials, Merck’s corporate venturing unit is scoping an opportunity-filled landscape.

Radiopharmaceuticals developer Precirix completed an $88m series B round featuring Novo while corporate-backed kitchen technology provider Bear Robotics raised $81m.

UGent, VUB, UAntwerpen, UHasselt, ULiège, VITO and Imec are all among the partners of Qbic, which has raised $54m for its third fund.

Monthly analysis: February 2022

Comment by Adam Salkin, a partner in one of Israel’s leading law firms, Herzog, Fox & Neeman

Innovative region: Israel

Analysis by James Mawson, founder, Global Corporate Venturing and co-author of Transformative Innovation (with Christine Gulbranson)

Bernstein Management and JBG Smith helped accommodation provider Placemakr raise $90m while crypto custodian Hex Trust netted $88m in a round co-led by Animoca Brands.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.